학술논문
Phase 2 Trial of AT-101 in Combination With Docetaxel for Recurrent, Locally Advanced, or Metastatic Head-and-Neck Squamous Cell Carcinoma (HNSCC): Management of Recurrent Head-and-Neck Squamous Cell Carcinoma
Document Type
Abstract
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 1 February 2014 88(2):507-507
Subject
Language
ISSN
0360-3016